FUNI (Hypha Labs) EBIT per Share: $-0.01 (TTM As of Mar. 2026)


What is Hypha Labs EBIT per Share?

Hypha Labs FUNI +9.59% EBIT per Share is $-0.01 as of Mar. 2026. The stock has 2 warning signs investors should review. Among 168 Medical Diagnostics & Research companies, Hypha Labs ranks worse than 76.19% on this metric.

Hypha Labs's EBIT per Share for the three months ended in Mar. 2026 was $-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.01.

During the past 3 years, the average EBIT per Share Growth Rate was -11.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 2.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was 25.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Hypha Labs's EBIT per Share or its related term are showing as below:

FUNI' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -207   Med: 29.6   Max: 64.4
Current: -11.2

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Hypha Labs was 64.40% per year. The lowest was -207.00% per year. And the median was 29.60% per year.

FUNI's 3-Year EBIT Growth Rate is ranked worse than
76.19% of 168 companies
in the Medical Diagnostics & Research industry
Industry Median: 12.75 vs FUNI: -11.20

Hypha Labs's EBIT for the three months ended in Mar. 2026 was $-0.42 Mil.

Hypha Labs  (OTCPK:FUNI) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Hypha Labs EBIT per Share Related Terms

Hypha Labs EBIT per Share Historical Data

* Premium members only.

The historical data trend for Hypha Labs's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypha Labs EBIT per Share Chart

Hypha Labs Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.03 -0.00 -0.01 -0.02

Hypha Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.00 -0.00 -0.00 -0.00

Hypha Labs EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Hypha Labs's EBIT per Share for the fiscal year that ended in Sep. 2025 is calculated as

EBIT per Share(A: Sep. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-2.996/135.146
=-0.02

Hypha Labs's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

EBIT per Share(Q: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.42/159.451
=-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.01 mean?
Hypha Labs (FUNI) has a EBIT per Share of $-0.01 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Hypha Labs and its competitors. According to the industry distribution chart, Hypha Labs ranks #128 out of 168 companies in the Medical Diagnostics & Research industry, placing it in the top 76.2%.
Is Hypha Labs' EBIT per Share too high?
Hypha Labs' current EBIT per Share is $-0.01. Based on the distribution chart, Hypha Labs ranks #128 out of 168 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Hypha Labs' EBIT per Share compare to IVRO and IDTA?
According to the Medical Diagnostics & Research industry distribution chart, Hypha Labs ranks #128 out of 168 companies for EBIT per Share. This places Hypha Labs in the lower half of its industry. The industry median EBIT per Share is 12.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Diagnostics & Research company?
The median EBIT per Share among Medical Diagnostics & Research companies is 12.75, based on 168 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Hypha Labs and its competitors. For the Medical Diagnostics & Research industry, the median EBIT per Share is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hypha Labs's current EBIT per Share is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypha Labs stock overvalued right now?
Hypha Labs (FUNI) has a current EBIT per Share of $-0.01. The current EBIT per Share is $-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Hypha Labs (FUNI), the current EBIT per Share is $-0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypha Labs Business Description

Address 5940 S. Rainbow Boulevard, Las Vegas, NV, USA, 89118
Hypha Labs Inc engaged in the research, development, and commercialization of the Hypha Micropearl accelerator, an in-home, web-based, computer-controlled bioreactor designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company's easy-to-use device, together with replaceable cartridges ordered through its exclusive app, safely and effectively produced enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contained active mushroom ingredients in a concentrated, easy-to-handle, tasteless, and odorless form that could be incorporated into various foods and beverages without altering flavor.